NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market Wednesday that its fourth quarter revenues rose 32 percent year over year, driven by what it said were record numbers for both reproductive health test volume and revenues, and across-the-board increases in average revenue per test.

CombiMatrix reported total revenues of $3.5 million for the three months ended Dec. 31, 2016, compared to $2.7 million for the fourth quarter of 2015.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.